|
|
|
|
||
Re: The market just doesn’t fully see the big picture here for their drug for AH: this chart would indicate a fair number of jumps into the $2 range over the history of this company. If it follows suit as we go into the last patient treated in mid 2023... |
return to message board, top of board |